Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2024Cardiovascular DiabetologyOpen Access

Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSangmo HongKKKyung‐Soo KimKHKyungdo Han

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hong et al. (2024) studied this question.

synapsesocial.com/papers/68e5fda8b6db643587590fd6https://doi.org/10.1186/s12933-024-02353-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fenofibrate therapy and risk of heart failure outcomes in patients with Type 2 diabetes: a propensity-matched cohort study2025 · 5 citations
  2. 2Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT2024 · 13 citations
  3. 3Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study2019 · 96 citations
  4. 4Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study2024 · 6 citations
  5. 5Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis2026